Heron Therapeutics, Inc.HRTXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P57
Within normal range
vs 3Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -22.47% |
| 2024 | 61.68% |
| 2023 | 59.98% |
| 2022 | 27.76% |
| 2021 | -10.03% |
| 2020 | -48.35% |
| 2019 | 35.05% |
| 2018 | -12.63% |
| 2017 | -27.00% |
| 2016 | -70.77% |